Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gabapentin 6% cream
0407030ADAAABAB
|
Gabapentin (Neuropathic Pain) | Gabapentin (Neuropathic Pain) | Central Nervous System | 3 |
|
Galcanezumab 120mg/1ml inj pre-filled disposable devices
0407042S0AAAAAA
|
Galcanezumab | Galcanezumab | Central Nervous System | 3 |
|
Ixyldone 40mg modified-release tablets
0407020ADBTAFAH
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 3 |
|
Kytril 1mg tablets
0406000M0BBABAB
|
Kytril | Granisetron hydrochloride | Central Nervous System | 3 |
|
Maneo 200mg modified-release tablets
040702040BUACAE
|
Maneo | Tramadol hydrochloride | Central Nervous System | 3 |
|
Matever 1g tablets
0408010A0BCAAAC
|
Matever | Levetiracetam | Central Nervous System | 3 |
|
Melatonin 2.5mg tablets
0401010ADAACRCR
|
Melatonin | Melatonin | Central Nervous System | 3 |
|
Modecate 25mg/1ml solution for injection ampoules (Sanofi)
0402020L0BBABAC
|
Modecate | Fluphenazine decanoate | Central Nervous System | 3 |
|
Morphine 0.1% in Intrasite gel
0407020Q0AAFXFX
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 3 |
|
Morphine tartrate 10mg/1ml / Cyclizine tartrate 50mg inj amp
040702020AAAAAA
|
Morphine tartrate/cyclizine tartrate | Morphine tartrate and cyclizine tartrate | Central Nervous System | 3 |
|
Naltrexone 1.5mg capsules
0410030E0AAANAN
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 3 |
|
Naltrexone 1.5mg/5ml oral solution
0410030E0AAAUAU
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 3 |
|
Nicorette 10mg patches
0410020B0BBADAT
|
Nicorette | Nicotine | Central Nervous System | 3 |
|
Night Nurse capsules
0407010X0CMABA0
|
Night Nurse | Paracetamol combined preparations | Central Nervous System | 3 |
|
NiQuitin Minis Cherry 1.5mg lozenges
0410020B0BDAQBP
|
NiQuitin | Nicotine | Central Nervous System | 3 |
|
Olanzapine 10mg powder for solution for injection vials
040201060AAANAN
|
Olanzapine | Olanzapine | Central Nervous System | 3 |
|
Oprymea 0.26mg modified-release tablets
0409010W0BDAEAE
|
Oprymea | Pramipexole | Central Nervous System | 3 |
|
Paracetamol 120mg/5ml oral suspension 5ml sachets
0407010H0AADJDJ
|
Paracetamol | Paracetamol | Central Nervous System | 3 |
|
Phenobarbital 300mg/5ml oral liquid
0408010N0AACTCT
|
Phenobarbital | Phenobarbital | Central Nervous System | 3 |
|
Ralnea XL 4mg tablets
0409010H0BEABAL
|
Ralnea XL | Ropinirole hydrochloride | Central Nervous System | 3 |
|
Reagila 1.5mg capsules
0402010AJBBAAAA
|
Reagila | Cariprazine | Central Nervous System | 3 |
|
Ropiqual XL 8mg tablets
0409010H0BKACAM
|
Ropiqual | Ropinirole hydrochloride | Central Nervous System | 3 |
|
Selegiline 10mg/5ml oral solution
0409010T0AAALAL
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | 3 |
|
Sudafed Blocked Nose & Sinus capsules
0407010X0CYAHA0
|
Sudafed (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | 3 |
|
Tadomon 100mg prolonged-release tablets
0407020AGBDABAD
|
Tadomon | Tapentadol | Central Nervous System | 3 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.